Non-alcoholic fatty liver disease: An expanded review

doi:10.4254/wjh.v9.i16.715

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 16

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (24684)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-5) series.

Item

Count

PDF

2370

WORD

479

HTML

18999

Tables (1-5)

171

Sum=22019

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1395

Download

1270

Sum=2665

Jun 8, 2017 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (496)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Hepatol. Jun 8, 2017; 9(16): 715-732
Published online Jun 8, 2017. doi: 10.4254/wjh.v9.i16.715

Table 5 Factors to be assessed in the evaluation of a patient with suspected non-alcoholic fatty liver disease[32]

Factor

Personal and family history of diabetes, hypertension and CVD

Alcohol use: < 20 g/d (women), < 30 g/d (man)

Waist circumference, BMI, change in body weight

Hepatitis B/C infection

Liver enzymes

History of steatosis-associated drug use

Fast blood glucose, hemoglobin A1c

Serum total and HDL-cholesterol, triacylglycerol, uric acid

Undertaken due to clinical suspicion

Ultrasound

Hemochromatosis testing: Ferritin and transferrin saturation

Celiac disease: IgA and tissue transglutaminase

Thyroid disease: TSH level (T3/T4)

Polycystic ovarian syndrome

Wilson’s disease: Ceruloplasmin

Autoimmune disease: ANA, AMA, SMA

Alpha-1 antitrypsin deficiency: Alpha-1-antitrypsin level

ANA: Anti-nuclear antibody; AMA: Anti-mitochondrial antibody; SMA: Anti-smooth muscle antibody; CVD: Cardiovascular disease; BMI: Body mass index; HDL: High density lipoprotein; TSH: Thyroid stimulating hormone.

Citation: Benedict M, Zhang X. Non-alcoholic fatty liver disease: An expanded review. World J Hepatol 2017; 9(16): 715-732
URL: https://www.wjgnet.com/1948-5182/full/v9/i16/715.htm
DOI: https://dx.doi.org/10.4254/wjh.v9.i16.715